Skip to main content

Find Clinical Trials

Home
Conditions
CTIT-Chemotherapy Induced Thrombocytopenia

Clinical trial condition

CTIT-Chemotherapy Induced Thrombocytopenia

Explore clinical trials studying CTIT-Chemotherapy Induced Thrombocytopenia. Study availability and eligibility vary by location and protocol.

4 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

CTIT-Chemotherapy Induced Thrombocytopenia trial results

Not yet recruiting

A Clinical Study of Hetrombopag for Prevention of Thrombocytopenia Induced by Gemcitabine Plus Cisplatin in the Treatment of Nasopharyngeal Carcinoma

NCT07252375

Conditions: CTIT-Chemotherapy Induced Thrombocytopenia, Carcinoma, Head and Neck Neoplasms, +13 more
Locations: Not specified

View Trial Details

Not yet recruiting

Hetrombopag for the Prevention of ADC-Induced Thrombocytopenia in Breast Cancer: An Exploratory, Dual-Cohort, Phase 2 Study

NCT07243418

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +5 more
Locations: Not specified

View Trial Details

Not yet recruiting

A Multicenter, Open-label, Randomized Controlled Trial Evaluating the Efficacy and Safety of Romiplostim N01 in the Treatment of Thrombocytopenia Associated With Concurrent/Sequential Chemoradiotherapy and Chemotherapy Combined With/Without Immunotherapy in Solid Tumors

NCT07185893

Conditions: Blood Platelet Disorders, CTIT-Chemotherapy Induced Thrombocytopenia, Cytopenia, +5 more
Locations: The Fourth Hospital of Hebei Medical University Shijiazhuang, Hebei, China

View Trial Details

Enrolling by invitation

TPO Combined With TPORA for Solid Tumors Effectiveness of cTit Above Degree II

NCT06769685

Conditions: CTIT-Chemotherapy Induced Thrombocytopenia
Locations: Jinhua Central Hospital Jinhua, Zhejiang, China

View Trial Details